GL1X · GenesisL1 explorer

Research workbench

Crystal structure of calcium ATPase with bound ADP and cyclopiazonic acid

Analyse Crystal structure of calcium ATPase with bound ADP and cyclopiazonic acid in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2OA0
Type
protein
Length
980 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
SARCOPLASMIC/ENDOPLASMIC reticulum calcium ATPase 1
EC
3.6.3.8
UniProt
P04191
Ligands
CZA, ADP, MG
Pockets
11 · best druggability 0.81

Structure

x-ray diffraction · 1 distinct chain · 45% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASARCOPLASMIC/ENDOPLASMIC reticulum calcium ATPase 1 (EC 3.6.3.8)protein98045% helix, 16% strandP04191

Ligands and binding sites

  • CZA · (6ar,11as,11br)-10-acetyl-9-hydroxy-7,7-dimethyl-2,6, 6A,7,11A,11B-hexahydro-11H-pyrrolo[1',2':2, 3]isoindolo[4,5,6-cd]indol-11-one · ligand · chains A
  • ADP · Adenosine-5'-diphosphate · ligand · chains A
  • MG · Magnesium ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

11 pockets found on a 1 Å grid, 6 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111580.810.8291MG, ADP
26500.810.8562CZA
35060.660.7854empty
43310.640.8037empty
51840.560.8030empty

Compared structures

  • 2OA0 · Crystal structure of Calcium ATPase with bound ADP and cyclopiazonic acid · the same entry in another collection · chain A against A, TM-score 1.00
  • P04191 · AlphaFold monomer V2.0 prediction for SARCOPLASMIC/ENDOPLASMIC reticulum calcium ATPase 1… · a predicted model of the same protein · chain A against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.